Cardiovascular disease under-recognised in COPD

Sponsored by A. Menarini Pty Ltd

Clinicians should be doing more to screen for and manage cardiovascular risk in their patients with COPD. New Zealand’s Professor Robert Hancox told the Respiratory Insights Forum in Melbourne that cardiovascular disease was present in 25-50% of patients hospitalised for exacerbations. Despite contributing to poorer outcomes in COPD patients, cardiovascular disease remained under-recognised in this ...

Already a member?

Login to keep reading.

© 2022 the limbic